From: Anxiety management in Australian general practice: an analysis of encounters from 2006 – 2016
Benzodiazepines | SSRIs or SNRIs | CAE | Psychologist Referral | |||||
---|---|---|---|---|---|---|---|---|
Variable | Proportion (95%CI) | Adjusted OR (95%CI) | Proportion (95% CI) | Adjusted OR (95%CI) | Proportion (95% CI) | Adjusted OR (95%CI) | Proportion (95% CI) | Adjusted OR (95%CI) |
Patient sex | p < .0001 | p < .0001 | p = .729 | p = .055 | ||||
Male | 34.3% (32.8–35.7) | Ref group | 39.5% (38.2–40.8) | Ref group | 11.8% (11.1–12.6) | Ref group | 19.9% (18.9–20.8) | Ref group |
Female | 28.1% (27.2–29.0) | 0.81 (0.75–0.87) | 45.6% (44.7–46.6) | 1.21 (1.13–1.29) | 12.4% (11.9–12.9) | 1.02 (0.92–1.12) | 21.6% (20.9–22.3) | 1.08 (1.00–1.17) |
Patient age | p < .0001 | p < .0001 | p < .0001 | p < .0001 | ||||
0–14 years | 0.1% (-0.1–0.4) | 0.01 (< 0.001–0.04) | 39.5% (35.7–43.4) | 0.76 (0.60–0.96) | 39.1% (35.3–42.9) | 26.06 (15.9–42.73) | 6.5% (4.7–8.3) | 0.37 (0.25–0.55) |
15–24 years | 10.1% (8.9–11.4) | 0.25 (0.20–0.30) | 50.2% (48.0–52.3) | 1.38 (1.17–1.63) | 23.1% (21.4–24.9) | 14.14 (8.86–22.55) | 26.4% (24.6–28.1) | 1.90 (1.56–2.31) |
25–39 years | 26.3% (24.8–27.8) | 0.72 (0.62–0.84) | 45.3% (43.8–46.9) | 1.20 (1.05–1.39) | 16.7% (15.7–17.7) | 10.00 (6.29–15.90) | 24.5% (23.3–25.6) | 1.78 (1.49–2.14) |
40–59 years | 32.2% (30.9–33.4) | 0.87 (0.75–0.99) | 43.9% (42.7–45.2) | 1.22 (1.06–1.39) | 10.5% (9.8–11.1) | 6.73 (4.25–10.65) | 22.2% (21.3–23.1) | 1.55 (1.30–1.85) |
60–80 years | 39.1% (37.8–40.5) | 0.88 (0.77–1.01) | 41.0% (39.5–42.4) | 1.12 (0.99–1.28) | 5.0% (4.4–5.5) | 3.43 (2.15–5.49) | 17.0% (16.0–18.0) | 1.30 (1.08–1.56) |
80 + years | 44.0% (41.5–46.4) | Ref group | 37.9% (35.5–40.4) | Ref group | 1.5% (0.9–2.1) | Ref group | 13.0% (11.4–14.6) | Ref group |
Socioeconomic status | p < .0001 | p = .095 | p = .317 | p = .380 | ||||
Most advantaged | 27.0% (26.0–27.9) | 0.85 (0.78–0.92) | 45.6% (44.5–46.7) | 1.07 (0.99–1.16) | 13.3% (12.7–13.9) | 1.06 (0.95–1.18) | 21.3% (20.5–22.0) | 1.04 (0.95–1.13) |
Most disadvantaged | 35.4% (34.0–36.7) | Ref group | 40.6% (39.3–41.9) | Ref group | 10.4% (9.8–11.1) | Ref group | 20.6% (19.7–21.5) | Ref group |
Indigenous statusa | p = 0.227 | p = .179 | p = .529 | p = .445 | ||||
Indigenous | 37.9% (32.3–43.5) | 1.18 (0.90–1.54) | 35.1% (29.6–40.6) | 0.83 (0.62–1.09) | 12.3% (8.9–15.8) | 1.12 (0.78–1.61) | 21.9% (17.7–26.0) | 1.11 (0.85–1.46) |
Non-Indigenous | 30.5% (29.5–31.4) | Ref group | 43.9% (43.0–44.9) | Ref group | 12.1% (11.6–12.6) | Ref group | 20.8% (20.2–21.5) | Ref group |
Language background | p < .0001 | p = .0005 | p = .0001 | p = .003 | ||||
Non-English speaking | 28.2% (25.5–30.8) | 0.73 (0.63–0.85) | 51.6% (48.7–54.6) | 1.28 (1.11–1.47) | 7.9% (6.5–9.3) | 0.64 (0.51–0.80) | 15.4% (13.5–17.3) | 0.77 (0.65–0.92) |
English speaking | 30.8% (29.8–31.7) | Ref group | 43.3% (42.3–44.2) | Ref group | 12.3% (11.8–12.9) | Ref group | 21.2% (20.6–21.9) | Ref group |
Commonwealth HCC | p < .0001 | p < .0001 | p < .0001 | p < .0001 | ||||
Yes | 42.2% (40.9–43.5) | 2.50 (2.31–2.72) | 39.1% (37.9–40.3) | 0.80 (0.75–0.86) | 8.0% (7.5–8.6) | 0.78 (0.70–0.86) | 17.2% (16.4–17.9) | 0.66 (0.61–0.71) |
No | 18.4% (17.6–19.2) | Ref group | 48.5% (47.4–49.7) | Ref group | 16.3% (15.6–17.0) | Ref group | 24.9% (24.0–25.8) | Ref group |
Type of anxiety | p < .0001 | p < .0001 | p < .0001 | p < .0001 | ||||
New problem | 16.3% (15.2–17.4) | 0.43 (0.39–0.48) | 55.6% (54.0–57.2) | 1.85 (1.71–2.01) | 20.8% (19.6–22.1) | 2.05 (1.85–2.27) | 16.9% (15.8–18.1) | 0.62 (0.56–0.68) |
Existing problem | 34.6% (33.4–35.7) | Ref group | 40.6% (39.5–41.7) | Ref group | 10.0% (9.5–10.5) | Ref group | 23.6% (22.8–24.3) | Ref group |